The risks associated with these therapies have severely limited progress in the development of novel IL-12 immunotherapies for ovarian cancer and for some other types of cancer. While oncologists ...

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune responses against hard-to-treat cancers, ...

A team of researchers from the Rice Biotech Launch Pad at Rice University in Houston developed the implantable “cytokine ...

IL-12, previously known primarily for its role in autoimmune diseases like Crohn's disease and rheumatoid arthritis, appears to play a pivotal role in Alzheimer's progression.

in patients with advanced ovarian cancer. IMNN-001 is a DNA immunotherapeutic drug that consists of an interleukin (IL)-12 expressing plasmid that allows for the durable, local, and targeted ...

IL-12, previously known primarily for its role in autoimmune diseases like Crohn's disease and rheumatoid arthritis, appears to play a pivotal role in Alzheimer's progression.